Of these two heterodimers, HIF-1 is a leading component attributed to tumor metabolism resulting in overexpression of glucose transporters as well as PDK1, an enzyme which hamper pyruvate entrance to the TCA cycle49. Here, SETD2 is linked to neoplasm.